Literature DB >> 3197748

Estimating reduced availability due to first pass elimination from relative total clearance and renal clearance.

D Brockmeier1.   

Abstract

A simple formula is presented for estimating the systemic availability of an orally administered drug from the relative total clearance (oral clearance) when renal clearance forms an important part of total clearance. Hepatic plasma flow is used in the equation and is represented by an average value taken from the literature. The formula is applied to data for cimetidine discussed in the literature. A further application is demonstrated for a drug under development for which an intravenous formulation was not available. It is possible to estimate the upper and lower limit of availability if some information on the amount of drug absorbed is available.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197748     DOI: 10.1007/bf00561371

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.

Authors:  D P Vaughan; A Trainor
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

3.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

4.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

5.  Cimetidine bioavailability and variable renal clearance.

Authors:  A Grahnén
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Bioavailability under variable renal clearance conditions.

Authors:  S Oie; D Jung
Journal:  J Pharm Sci       Date:  1979-01       Impact factor: 3.534

7.  Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data.

Authors:  A Somogyi; M Eichelbaum; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.